Compass Pathways Plc

Market Cap

$2B

Healthcare·Medical Care Facilities·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$11.73+$5.18 (+79.08%)

Jun 8, 2026

52W High $14.1952W Low $2.35

Company Details

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment o...

CEO

—

IPO Date

Sep 18, 2020

Website

compasspathways.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$179M

EPS (Diluted)

Free Cash Flow

-$160M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

Q1 2026

May 13, 2026

FY 2025

Mar 24, 2026

Q4 2025

Mar 24, 2026

Q3 2025

Nov 4, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee